輸入代號或公司名稱後按 Enter
6541

泰福-KY

-0.75 (-2.38%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
30.80505成交張數本益比1.64股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-1.44-5.54-3.83-173.5%-7.41%-29.78%
2026Q1-1.47-5.53-3.89-292.6%-7.03%-26.08%
2025Q4-1.60-6.13-4.21-235.0%-7.19%-45.55%
2025Q3-1.03-6.16-2.73-218.2%-5.03%-37.98%
2025Q2-1.43-6.99-3.40-727.0%-6.53%-44.17%
2025Q1-2.07-7.79-4.66-934.1%-14.46%-48.00%
2024Q4-1.63-8.81-2.78-9900.7%-27.25%-161.17%
2024Q3-1.86-11.13-3.18-2768.5%-24.25%-128.72%
2024Q2-2.23-12.93-3.67-2156.2%-38.94%-110.65%
2024Q1-3.09-14.44-4.18-12456.4%-68.16%-277.23%
2023Q4-3.96-16.41-5.18-5700.6%-47.26%-193.18%
2023Q3-3.66-13.85-5.05-9899.0%-31.97%-128.71%
2023Q2-3.74-11.29-5.06-2959.7%-36.25%-100.94%
2023Q1-5.06-8.71-6.08-2018.0%-50.89%-109.86%
2022Q4-1.40-4.55-4.78-6046.9%-29.15%-78.41%
2022Q3-1.10-4.08-4.04-4852.6%-19.95%-60.30%
2022Q2-1.16-4.17-4.27-14029.5%-18.34%-75.26%
2022Q1-0.90-4.17-3.32-10619.1%-12.55%-61.59%
2021Q4-0.93-4.52-3.51-7238.6%-11.83%-56.99%
2021Q3-1.19-5.31-3.99-70959.8%-16.02%-73.03%
2021Q2-1.15-5.70-3.79-18.50%-92.95%
2021Q1-1.26-6.51-4.15-17.05%-80.75%
2020Q4-1.71-7.40-4.70-23.27%-74.47%
2020Q3-1.58-7.65-4.56-151975.7%-27.83%-106.10%
2020Q2-1.96-8.69-5.61-25.99%-93.19%
2020Q1-2.14-8.73-6.17-22.45%-76.17%
2019Q4-1.96-8.52-5.36-18.81%-62.77%
2019Q3-2.63-8.23-6.88-23.05%-60.03%
2019Q2-2.00-7.45-5.33-15.08%-63.21%
2019Q1-1.94-8.16-5.17-12.94%-58.11%
2018Q4-1.67-7.60-4.49-10.17%-47.56%
2018Q3-1.84-4.75-12.56%
2018Q2-2.71-6.41-20.22%
2018Q1-1.37-3.29-9.22%